Analysts at Zacks Investment Research upgraded shares of Ritter Pharmaceuticals Inc (NASDAQ: RTTR) from Sell to Hold today. With a rating of Hold on the stock, Ritter Pharmaceuticals Inc has a 52-week high of $3.13. The one-year price target of …

Analysts at Zacks Investment Research upgraded shares of Ritter Pharmaceuticals Inc (NASDAQ: RTTR) from Sell to Hold today.With a rating of Hold on the stock, the company has a 52-week high of $3.17. The one-year price target of $5.33 is …

Shares of Ritter Pharmaceuticals Inc (NASDAQ: RTTR) were downgraded by analysts at Zacks in a note to itheir nvestors today. For comparison, a number of other analysts have commented on the company recently, and the company currently has a consensus …